Table 3.

HPV genotype distribution in cancerous and precancerous patients with HPV detected (n = 48).

Histological type	HPV 16	HPV 18	HPV 39, 68	HPV 45, 59	HPV 9 GTS	Multiple
SCC (type unknown)	14 (66.7%)	1 (4.76%)	0 (0.0%)	0 (0.0%)	2 (9.5%)	4 (19.0%)
Nonkeratinizing SCC	7 (50.0%)	0 (0.0%)	0 (0.0%)	2 (14.3%)	0 (0.0%)	5 (35.7%)
Keratinizing SCC	4 (66.7%)	1 (16.7%)	0 (0.0%)	0 (0.0%)	0 (0.0%)	1 (16.7%)
Mucinous adenocarcinoma	0 (0.0%)	1 (100.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
Histological differentiation of cancerous lesion
Well differentiated	14 (56.0%)	2 (8.0%)	0 (0.0%)	1 (4.0%)	2 (8.0%)	6 (24.0%)
Moderately differentiated	11 (68.7%)	0 (0.0%)	0 (0.0%)	1 (6.2%)	0 (0.0%)	4 (25.0%)
Poorly differentiated	0 (0.0%)	1 (100.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)	0 (0.0%)
Precancerous lesion
HSIL/CIN3	4 (80.0%)	0	0	0	1 (20.0%)	0
LSIL/CIN1	0	0	1 (100.0%)	0	0	0